Literature DB >> 8489301

[Disease-free survival in a patient with squamous cell lung carcinoma following complete response with the combination chemotherapy of cisplatin and etoposide].

M Taniwaki1, M Kakusui, M Imoto, T Takashima, S Misawa, K Kashima.   

Abstract

Disease-free survival is reported in a patient with non-small cell lung carcinoma successfully treated with the combination chemotherapy of cisplatin and etoposide (CDDP-ETOP). An 80-year-old woman was diagnosed as having squamous cell carcinoma of the lung with bone metastasis. Chest X-ray showed a tumor (64 x 68 mm in size) in the S1/4 segment of the right lobe, and CT scan revealed no apparent metastasis of hilar lymphnode. In March 1989, the patient achieved a complete response (CR) after two courses of CDDP-ETOP therapy, followed by ETOP(100mg) every two weeks and daily UFT (400 mg) for 10 months. Subsequently, a single course of CDDP-ETOP was administered as a consolidation therapy. The patient is alive with no evidence of recurrent disease for 3 years and half after achieving CR.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8489301

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  1 in total

1.  Ossification and increased bone mineral density with zoledronic acid in a patient with lung adenocarcinoma: A case report.

Authors:  Koichi Kurishima; Gen Ohara; Katsunori Kagohashi; Norio Takayashiki; Tomohiro Tamura; Toshihiro Shiozawa; Kunihiko Miyazaki; Mio Kawaguchi; Hiroaki Satoh; Nobuyuki Hizawa
Journal:  Exp Ther Med       Date:  2014-08-18       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.